论文部分内容阅读
2015年2月,人体再生复原科学世界知识产权发展进程中又获喜讯,徐荣祥教授的“药物组合物在制备治疗糖尿病溃疡药物中的用途”再获澳大利亚专利。继此项专利在欧洲和俄罗斯获得授权后,徐荣祥教授又拥有了该项技术在澳大利亚的专利授权,使损伤器官再生领域的世界性推进又迈上了一个新台阶。众所周知,糖尿病溃疡是当今世界医学界所面临的治疗难题,它不仅缺乏有效的冶疗方法,
In February 2015, the World Intellectual Property Agency for Human Regenerative Restoration won another good news in the intellectual property development process. Professor Xu Rongxiang won the Australian patent again for its use in the preparation of drugs for the treatment of diabetic ulcer. After the patent was granted in Europe and Russia, Professor Xu Rongxiang possesses the patent of the technology in Australia, bringing the worldwide promotion of the damaged organ regeneration to a new stage. It is well-known that diabetic ulcer is the treatment problem facing the medical profession in the world today. It not only lacks an effective method of treatment,